Article
The multi-functionality of CD40L and its receptor CD40 in atherosclerosis
1 Jan 2009
Abstract excerpt
Disrupting the CD40-CD40L co-stimulatory pathway reduces atherosclerosis and induces a stable atherosclerotic plaque phenotype that is low in inflammation and high in fibrosis. Therefore, inhibition of the CD40-CD40L pathway is an attractive therapeutic target to reduce clinical complications of atherosclerosis. The CD40-CD40L dyad is known to interact with other co-stimulatory molecules, to activate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
